Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial

Journal of the National Cancer Institute

Volumn 96, Issue 5, 2004, Pages 376-387

  Ganz, Patricia A ^a   Kwan, Lorna ^a   Stanton, Annette L ^a,b   Krupnick, Janice L ^c   Rowland, Julia H ^d   Meyerowitz, Beth E ^e   Bower, Julienne E ^b   Belin, Thomas R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; EDEMA; EMOTIONAL STABILITY; FEMALE; FOLLOW UP; HEALTH STATUS; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL HEALTH; MOOD; MUSCLE STIFFNESS; NIGHT SWEAT; OUTCOMES RESEARCH; PAIN; PARTIAL MASTECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SOCIAL STATUS; STATISTICAL ANALYSIS; SURVIVAL RATE; SYMPTOMATOLOGY; VAGINA DISEASE; WELLBEING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AFFECT; BREAST TUMOR; DEPRESSION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

ADULT; AFFECT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; MASTECTOMY; MIDDLE AGED; PATIENT EDUCATION; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; RESEARCH DESIGN; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

EID: 1542378199     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh060     Document Type: Article

References (59)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Maunsell E, Brisson J, Deschenes L. Psychological distress after initial treatment for breast cancer: A comparison of partial and total mastectomy. J Clin Epidemiol 1989;42:765-71.
3. Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA. The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 1990;65:1242-54.
4. Ganz PA, Schag CC, Polinsky ML, Heinrich RL, Flack VF. Rehabilitation needs and breast cancer: The first month after primary therapy. Breast Cancer Res Treat 1987;10:243-53.
5. Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 1992;69:1729-38.
6. Meyerowitz BE, Sparks FC, Spears IK. Adjuvant chemotherapy for breast carcinoma: Psychosocial implications. Cancer 1979;43:1613-8.
7. Meyerowitz BE. Psychosocial correlates of breast cancer and its treatments. Psychol Bull 1980;87:108-31.
8. Meyerowitz BE, Watkins IK, Sparks FC. Quality of life for breast cancer patients receiving adjuvant chemotherapy. Am J Nurs 1983;83:232-5.
9. Andrykowski MA, Curran SL, Studts JL, Cunningham L, Carpenter JS, McGrath PC, et al. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: A controlled comparison. J Clin Epidemiol 1996:49:827-34.
10. Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 1998;51:1285-92.
11. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Res Treat 1996;38:183-99.
12. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14.
13. Ganz PA, Rowland JH, Meyerowitz BE, Desmond KA. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res 1998;152:396-411.
14. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743-53.
15. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study [published erratum appears in J Natl Cancer Inst 2002;94: 463]. J Natl Cancer Inst 2002;94:39-49.
16. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, et al. National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
17. Gelber RD, Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 1986;4:1772-9.
18. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, et al. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 2003;21:976-83.
19. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 [published erratum appears in J Clin Oncol 2003;21:2226]. J Clin Oncol 2003;21:1431-9.
20. Ward SE, Viergutz G, Tormey D, deMuth J, Paulen A. Patients' reactions to completion of adjuvant breast cancer therapy. Nurs Res 1992;41:362-6.
21. Fertig DL. Depression in patients with breast cancer: prevalence, diagnosis, and treatment. Breast J 1997;3:292-302.
22. Tross S, Holland JC. Psychological sequelae in cancer survivors. In: Holland JC, Rowland JH, editors. Handbook of psychooncology: Psychological care of the patient with cancer. New York (NY): Oxford University Press; 1989. p. 101-16.
23. Beisecker A, Cook MR, Ashworth J, Hayes J, Brecheisen M, Helmig L, et al. Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients. Psychooncology 1997;6:85-93.
24. Lethborg CE, Kissane D, Burns WI, Snyder R. "CAst adrift": the experience of completing treatment among women with early stage breast cancer. J Psychosoc Oncol 2000;18:73-90.
25. Green BL, Rowland JH, Krupnick JL, Epstein SA, Stockton P, Stern NM, et al. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 1998;39:102-11.
26. Maher EL. Anomic aspects of recovery from cancer. Soc Sci Med 1982; 16:907-12.
27. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992; 30:473-83.
28. Ware JE Jr. SF-36 Health Survey. Manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center; 1993. p. 10:1-10:38.
29. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
30. Cantril H. The pattern of human concerns. New Brunswick (NJ): Rutgers University Press; 1965.
31. Sears SR, Stanton AL, Kwan L, Krupnick JL, Rowland JH, Meyerowitz BE, et al. Recruitment and retention challenges in breast cancer survivorship research: Results from a multisite, randomized intervention trial in women with early stage breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1087-90.
32. Ware JE, Kosinki M, Keller SD. SF-36 physical and mental health summary scales: A user's manual. Boston (MA): The Health Institute; 1994. p. 8:1-8:42.
33. McDowell I, Newell C. Measuring health, a guide to rating scales and questionnaires. 2nd ed. New York (NY): Oxford University Press; 1996. p. 194-8.
34. Schag CA, Heinrich RL, Aadland RL, Ganz PA. Assessing problems of cancer patients: Psychometric properties of the cancer inventory of problem situations. Health Psychol 1990;9:83-102.
35. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
36. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: Its use in a community sample. Am J Psychiatry 1983;140:41-6.
37. Myers JK, Weissman MM. Use of a self-report symptom scale to detect depression in a community sample. Am J Psychiatry 1980;137:1081-4.
38. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999;17:2659-69.
39. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988;54:1063-70.
40. Busby DM, Christensen C, Crane DR, Larson JH. A revision of the dyadic adjustment scale for use with distressed and nondistressed couples: Construct hierarchy and multidimensional scales. J Marital Fam Ther 1995;21: 289-308.
41. Spanier GB. Measuring dyadic adjustment: New scales for assessing the quality of marriage and similar dyads. J Marriage Fam 1976;38:15-28.
42. Sherbourne CD. Social functioning: Sexual problems measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham (NC): Duke University Press; 1992. p. 195-204.
43. Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87:1372-82.
44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 1995; 57:289-300.
45. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: A review. J Clin Oncol 1991;9:1059-70.
46. Wapnir IL, Cody RP, Greco RS. Subtle differences in quality of life after breast cancer surgery. Ann Surg Oncol 1999;6:359-66.
47. Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry 1994; 16:267-76.
48. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 1999;17:2371-80.
49. Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: A prospective randomized study. J Clin Oncol 2001;19:2788-96.
50. Ganz PA, Schag CA, Cheng HL. Assessing the quality of life-a study in newly-diagnosed breast cancer patients. J Clin Epidemiol 1990;43:75-86.
51. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
52. Fallowfield LJ, Hall A. Psychosocial and sexual impact of diagnosis and treatment of breast cancer. Br Med Bull 1991;47:388-99.
53. Berglund G, Nystedt M, Bolund C, Sjoden PO, Rutquist LE. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: A prospective randomized study. J Clin Oncol 2001;19:2788-96.
54. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-8.
55. Ganz PA. Cognitive dysfunction following adjuvant treatment of breast cancer: A new dose-limiting toxic effect? J Natl Cancer Inst 1998;90:182-3.
56. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000;18:2695-701.
57. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485 93.
58. Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: Current knowledge and research directions. J Natl Cancer Inst 2003;95:190-7.
59. Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol. In press 2004.